Riskpilot← Back to searchSign inGet full accessBoule Medical AB
ABActiveOrg 5561286542Fagerstagatan 7Manufacture of instruments and appliances for measuring, testing and navigation · NACE 2651Est. 196950-99 employees
Revenue 2024
SEK 324,9M
-7% vs 2023
EBITDA margin
-23.8%
-12% vs 2023
Equity ratio
23.1%
Financial strength
Net profit 2024
SEK -79,5M
-27% vs 2023
| Revenue | SEK 324,9M | -7% |
| EBITDA | SEK -77,3M | -12% |
| Net profit | SEK -79,5M | -27% |
| Total assets | SEK 341,5M | +9% |
| Equity | SEK 78,8M | +106% |
| Employees | — | — |
Legal name
Boule Medical AB
Org number
5561286542
Legal form
Aktiebolag
NACE code
2651 · Manufacture of instruments and appliances for measuring, testing and navigation
Founded
8 september 1969
Share capital
SEK 1 000 000
Employees
50-99
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall utöva konsulterande verksamhet, konstruera, tillverka och försälja elektriska och mekaniska instrument samt bedriva därmed förenlig rörelse.
Address
Fagerstagatan 7
Email
info@bm.boule.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 265 188 | 299 894 | 323 053 | 350 879 | 324 881 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −51 852 | −43 500 | −76 970 | −68 982 | −77 348 |
| Depreciation & amort. | — | — | — | — | — |
| EBIT | −51 852 | −43 500 | −76 970 | −68 982 | −77 348 |
| Net financials | −2 219 | −2 844 | −7 279 | −9 150 | −16 418 |
| Profit before tax | −42 557 | −46 344 | −84 248 | −78 131 | −93 766 |
| Tax | −0 | 9 497 | 16 664 | 15 468 | 14 287 |
| Net profit | −42 557 | −36 847 | −67 584 | −62 663 | −79 479 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 337 294 | 247 816 | 297 054 | 314 090 | 341 520 |
| Equity | 66 331 | 23 484 | 900 | 38 236 | 78 757 |
| Long-term debt | 16 011 | 34 746 | 61 915 | 57 744 | 49 801 |
| Short-term debt | 253 953 | 188 086 | 232 740 | 216 974 | 211 750 |
| Total debt | 269 964 | 222 832 | 294 655 | 274 718 | 261 551 |
EBITDA margin
-23.8%
This company
15.8%
Market median
-251% vs market
20202024
Equity ratio
23.1%
This company
38.2%
Market median
-40% vs market
20202024
Return on equity
-100.9%
This company
18.4%
Market median
-648% vs market
20202024
Net profit margin
-24.5%
This company
8.1%
Market median
-402% vs market
20202024
Asset turnover
0.95×
This company
1.12×
Market median
+15% vs market
20202024
Debt / equity
3.34×
This company
0.62×
Market median
-439% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LG Chief Auditor | Chief Auditor | 2022 |
TN Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (2) | ||
JF Chief Executive Officer | Chief Executive Officer | 2021 – 2024 |
KL Chief Auditor | Chief Auditor | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Chairman | 2026 | |
| Former (6) | ||
| Chairman | 2021 – 2022 | |
| Chairman | 2022 – 2024 | |
| Chairman | 2024 – 2026 | |
| Board of Directors | 2024 – 2025 | |
| Chairman | 2020 – 2021 | |
| Board of Directors | 2020 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Boule Diagnostics AB
Boule Medical AB (this company)Llc Boule ProductionBOULE MEDICAL S.A DE C.VLLC BOULE PRODUCTIONLlc Boule MedicalLLC BOULE MEDICALBoule Medical S.A De C.vBoard members of Boule Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jesper Filip Gustaf B Söderqvist | Chief Executive Officer | 0 companies |
| Lars Gustaf Kylberg | Chief Auditor | 0 companies |
| Torben Nielsen | Chief Executive Officer | 0 companies |
| Karl Leonard Daun | Chief Auditor | 0 companies |
| Simonetta Tumbiolo | Board of Directors | 0 companies |
| Anna Christina Rubenhag | Chairman | 0 companies |
| Michael Carl Ewert af Winklerfelt | Chairman | 0 companies |
| Jan Håkan Benjaminson | Chairman | 0 companies |
| Holger Lembrér | Chairman | 0 companies |
| Ayshat Bislieva | Board of Directors | 0 companies |
| Gustaf Peter Reinhold von Ehrenheim | Chairman | 0 companies |
| Kiarash Moaierifar | Board of Directors | 0 companies |